References
- Goldstein D S. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation 1983; 68: 234–240
- Guo G B., Abboud F M. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 1984; 246: H80–H89
- Fukiyama K. Central modulation of baroreceptor reflex by angiotensin. Jpn Heart J 1973; 14: 135–139
- Shimamoto K, Ishida H, Nakahashi Y, Nishitani T, Hosoda S, Yokoyama T, Tanaka S, Iimura O. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clincal application in various hypertensive disease. Jpn Circ J 1984; 48: 1228–1235
- Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365–72
- Garner M G., Phippard A F., Fletcher P J., Maclean J M., Duggin F F., Horvath J S., Tiller D J. Effect of angiotensin II on baroreceptor reflex control of heart rate in conscious baboons. Hypertension 1987; 10: 628–634
- Ebert T J. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 1985; 7: 602–606
- Mancia G, Parati G, Pomidossi G, Grassi G, Bertinieri G, Buccino N, Ferrari A, Gregorini L, Rupoli L, Zanchetti A. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Caridiol 1982; 49: 1415–1419
- Clementi W A., Durst N L., McNay J L., Keeton T K. Captopril modifies the hemodynamic and neuroendocrine response to sodium nitroprusside in hypertensive patients. Hypertension 1986; 8: 229–237
- Joy M D., Lowe R D. Evidence that the area postrema mediated the central cardiovascular response to angiotensin II. Nature 1970; 228: 1303–1304
- Zimmeremann B G. Actions of angiotensin on adrenergic nerve endings. Fed Proc 1978; 37: 199–202
- Mento P F., Wilkes B M. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 1987; 9: III-42–III-48
- Phillips M I., Kimura B. Converting enzyme inhibitors and brain angiotensin. J Caridiovascular Pharmacol 1986; 8: S82–S90
- Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Clin Pharmacol Ther 1981; 30: 328–335
- Okamura T, Miyazaki M, Inagami T, Toda N. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 1986; 8: 560–565
- Bouthier J D., Safar M E., Benetos A, Simon A C., Levenson J A., Huges C M. Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension. Br J Clin Pharmacol 1986; 21: 137–142
- Dzau V J., Safer M E. Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation 1988; 77: 947–954
- Campagnole-Santos M J., Diz D I., Ferrario C M. Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension 1988; 11: I-167–I-171
- Cohen M L., Kurz K D. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK 421. J Pharmacol Exp Ther 1982; 220: 63–69